Impact of osmolality on burning sensations during and immediately after intramuscular injection of 0.5 ml of vaccine suspensions in healthy adults.

[1]  G. Brazeau,et al.  Current perspectives on pain upon injection of drugs. , 1998, Journal of pharmaceutical sciences.

[2]  M. Levine,et al.  Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants. , 1998, The Pediatric infectious disease journal.

[3]  L. Arendt-Nielsen,et al.  In vivo model of muscle pain: Quantification of intramuscular chemical, electrical, and pressure changes associated with saline-induced muscle pain in humans , 1997, Pain.

[4]  L. Arendt-Nielsen,et al.  Quantification of local and referred muscle pain in humans after sequential i.m. injections of hypertonic saline , 1997, Pain.

[5]  J. Fransson,et al.  Local Tolerance of Subcutaneous Injections , 1996, The Journal of pharmacy and pharmacology.

[6]  Y. Katayama,et al.  Heat and pain sensations induced by arterial injection of low-osmolality contrast media: a comparison of patients' discomfort with ionic saline, nonionic glucose, and vasodilator nitrate. , 1996, Academic radiology.

[7]  J. T. Jørgensen,et al.  Pain Assessment of Subcutaneous Injections , 1996, The Annals of pharmacotherapy.

[8]  S. Fareh,et al.  The role of an initial single‐blind placebo period in phase I clinical trials * , 1994, Fundamental & clinical pharmacology.

[9]  F. Howell,et al.  Pain and measles, mumps, and rubella vaccination. , 1991, Archives of disease in childhood.

[10]  M. Kenward,et al.  Design and Analysis of Cross-Over Trials , 1989 .

[11]  U. Speck,et al.  Contrast media and pain in peripheral arteriography. , 1980, Investigative radiology.

[12]  George E. Ehrlich.  Pharmacologie Clinique: Bases de la Thérapeutique , 1980 .

[13]  V. Usonis,et al.  Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children. , 1999, The Pediatric infectious disease journal.

[14]  M. Hoffman,et al.  Incompatibilités physicochimiques des médicaments injectables. , 1983 .